Momenta Pharmaceuticals, Inc. (Jobs) Sees Longer US Review for Generic Lovenox

June 28, 2007 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

NEW YORK, June 28 (Reuters) - Momenta Pharmaceuticals Inc. said on Thursday a U.S. review of its application to sell a generic version of Sanofi-Aventis' big-selling Lovenox blood-thinner is taking longer than it previously projected.

Twitter
LinkedIn
Facebook
Email
Print

Clinical research Postmarket research